A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers.
Soltan MA, Eldeen MA, Eid RA, Alyamani NM, Alqahtani LS, Albogami S, Jafri I, Park MN, Alsharif G, Fayad E, Mohamed G, Osman R, Kim B, Zaki MSA.
Soltan MA, et al. Among authors: eldeen ma.
Front Mol Biosci. 2023 Mar 23;10:1017148. doi: 10.3389/fmolb.2023.1017148. eCollection 2023.
Front Mol Biosci. 2023.
PMID: 37033447
Free PMC article.